NovoCure Limited (NVCR) Ownership

$29.66

south_east
-$0.53 (-1.76%)
Day's range
$29.49
Day's range
$30.78

NovoCure Limited Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/13/2025 16.23 M $483.66 M   -0.01% 14.99%
BLACKROCK FUNDING, INC. /DE 02/07/2025 13.03 M $388.19 M   1.94% 12.03%
VANGUARD GROUP INC 02/11/2025 11.80 M $351.52 M   -0.41% 10.90%
CAPITAL INTERNATIONAL INVESTORS 02/13/2025 8.87 M $264.44 M   12.01% 8.20%
CAPITAL WORLD INVESTORS 02/13/2025 4.82 M $143.50 M   11.78% 4.45%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/14/2025 2.74 M $81.64 M   100.00% 2.53%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 2.40 M $71.54 M   -0.21% 2.22%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/14/2025 1.69 M $50.38 M   -39.76% 1.56%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 1.68 M $50.18 M   -27.49% 1.56%
BAILLIE GIFFORD & CO 01/31/2025 1.16 M $34.61 M   -30.01% 1.07%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 1.07 M $31.85 M   27.37% 0.99%
GOLDMAN SACHS GROUP INC 02/11/2025 941,490 $28.06 M   19.82% 0.87%
FEDERATED HERMES, INC. 02/13/2025 907,987 $27.08 M   -8.97% 0.84%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/14/2025 870,155 $25.93 M   -15.39% 0.80%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 836,214 $24.92 M   1.43% 0.77%
PALO ALTO INVESTORS LP 02/14/2025 814,191 $24.26 M   37.18% 0.75%
MILLENNIUM MANAGEMENT LLC 02/14/2025 735,227 $21.91 M   171.49% 0.68%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 734,354 $21.88 M   -1.32% 0.68%
FRONTIER CAPITAL MANAGEMENT CO LLC 02/14/2025 726,324 $21.64 M   -16.65% 0.67%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 701,645 $20.91 M   -22.73% 0.65%
GRANITE INVESTMENT PARTNERS, LLC 02/13/2025 686,727 $20.46 M   100.00% 0.63%
C WORLDWIDE GROUP HOLDING A/S 02/04/2025 621,784 $18.53 M   19.17% 0.57%
COATUE MANAGEMENT LLC 02/14/2025 608,672 $18.14 M   0.00% 0.56%
TWO SIGMA ADVISERS, LP 02/14/2025 586,000 $17.46 M   -39.21% 0.54%
TWO SIGMA INVESTMENTS, LP 02/14/2025 561,120 $16.72 M   -24.17% 0.52%
EMERALD ADVISERS, LLC 02/11/2025 547,557 $16.32 M   100.00% 0.51%
UBS GROUP AG 02/14/2025 524,109 $15.62 M   238.20% 0.48%
JANE STREET GROUP, LLC 02/14/2025 484,300 $14.43 M   81.52% 0.45%
BARCLAYS PLC 02/13/2025 460,055 $13.71 M   1.40% 0.43%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 437,772 $13.05 M   2.70% 0.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 396,700 $11.82 M   202.59% 0.37%
JPMORGAN CHASE & CO 02/12/2025 367,702 $10.96 M   -11.17% 0.34%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 358,952 $10.70 M   -1.54% 0.33%
SILVERCREST ASSET MANAGEMENT GROUP LLC 02/14/2025 348,307 $10.38 M   -29.79% 0.32%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 335,218 $9.99 M   223.10% 0.31%
EMERALD MUTUAL FUND ADVISERS TRUST 02/14/2025 325,255 $9.69 M   100.00% 0.30%
BANK OF NEW YORK MELLON CORP 02/04/2025 322,530 $9.61 M   3.22% 0.30%
NORDWAND ADVISORS, LLC 02/07/2025 312,155 $9.30 M   -89.70% 0.29%
QUANTINNO CAPITAL MANAGEMENT LP 02/14/2025 294,639 $8.78 M   17.14% 0.27%
SUPERSTRING CAPITAL MANAGEMENT LP 02/14/2025 286,970 $8.55 M   -26.93% 0.27%
MARSHALL WACE, LLP 02/13/2025 270,952 $8.07 M   -65.25% 0.25%
TD ASSET MANAGEMENT INC 02/11/2025 253,154 $7.54 M   -27.83% 0.23%
UBS GROUP AG 02/14/2025 229,700 $6.85 M   14.85% 0.21%
SWISS NATIONAL BANK 02/10/2025 202,200 $6.03 M   1.30% 0.19%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 200,000 $5.96 M   100.00% 0.18%
ENGINEERS GATE MANAGER LP 02/14/2025 198,933 $5.93 M   -34.29% 0.18%
DEUTSCHE BANK AG\ 02/14/2025 194,327 $5.79 M   20.67% 0.18%
INVESCO LTD. 02/13/2025 189,474 $5.65 M   72.60% 0.18%
D. E. SHAW & CO., INC. 02/14/2025 185,303 $5.52 M   -71.51% 0.17%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 184,800 $5.51 M   18.84% 0.17%

NovoCure Limited institutional Ownership - FAQ's

During the previous two years, 338 institutional investors and hedge funds held shares of NovoCure Limited. The most heavily invested institutionals were:

FMR LLC: 16.23 M

BlackRock Funding, Inc. /DE: 13.03 M

VANGUARD GROUP INC: 11.8 M

Capital International Investors: 8.87 M

Capital World Investors: 4.82 M

Soleus Capital Management, L.P.: 2.74 M

84.59% of NovoCure Limited stock is owned by institutional investors.

Institutional investors have bought a total of 108.10 M shares in the last 24 months. This purchase volume represents approximately $3.21 B in transactions.